Actinium Pharmaceuticals Dividends

ATNM Stock  USD 1.44  0.03  2.13%   
At this time, Actinium Pharmaceuticals' Dividends Paid is very stable compared to the past year. As of the 30th of November 2024, Dividend Yield is likely to grow to 0.000012, while Dividend Payout Ratio is likely to drop (0.000043). Actinium Pharmaceuticals' past performance could be the main factor of why investors trade Actinium Pharmaceuticals stock today. Investors should clearly understand every aspect of the Actinium Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Actinium Pharmaceuticals' dividend schedule and payout information. Actinium Pharmaceuticals dividends can also provide a clue to the current valuation of Actinium Pharmaceuticals.
Last ReportedProjected for Next Year
Dividends Paid 900.00  907.60 
Dividend Paid And Capex Coverage Ratio(309.38)(324.85)
One of the primary advantages of investing in dividend-paying companies such as Actinium Pharmaceuticals is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Actinium Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.

Actinium Pharmaceuticals Dividends Paid Over Time

Today, most investors in Actinium Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Actinium Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Actinium Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period.
   Dividends Paid   
       Timeline  

Actinium Pharmaceuticals Historical Dividend Yield Growth

A solid dividend growth pattern of Actinium Pharmaceuticals could indicate future dividend growth is likely, which can signal long-term profitability for Actinium Pharmaceuticals. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period.
Dividend Yield is Actinium Pharmaceuticals dividend as a percentage of Actinium Pharmaceuticals stock price. Actinium Pharmaceuticals dividend yield is a measure of Actinium Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Actinium Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.
   Dividend Yield   
       Timeline  
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.39)
Revenue Per Share
0.003
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.88)
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: